Arcus Biosciences, Inc.
Arcus Biosciences, Inc.（RCUS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
rcus · 股价预测 · 18 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 18 位华尔街分析师
Buy
18 位分析师
共识
评级分布
12 个月目标价
High
$47.00
Consensus
$31.17
+33.7% upside
Low
$22.00
Median: $30 · Last Close: $23.32
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$31.17
33.7% upside
High Target
$47
101.5%
Low Target
$22
-5.7%
Current Price
$23.32
as of today
Based on analyst price targets, the RCUS stock price prediction for the next 12 months ranges from $22 to $47. The consensus RCUS price forecast of $31.17 implies 33.7% upside from the current price of $23.32.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $23.13 | ↓ 0.82% |
1-day model range: $23.01–$23.25. Peak: $23.25 (-0.82%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $22 | -6.7% |
| 2028 | $21 | -10.5% |
| 2029 | $20 | -12.6% |
| 2030 | $20 | -13.9% |
| 2031 | — | -14.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RCUS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-05-07 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-04-02 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-05 | Citigroup | Maintains | Buy→Buy |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-02 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-02-12 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2026-01-13 | Goldman Sachs | Upgrade ↑ | Neutral→Buy |
| 2026-01-08 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2025-12-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Arcus Biosciences, Inc. (RCUS) stock. Of the recent 93 rating actions, 2 were upgrades and 2 were downgrades. 18 analysts currently cover RCUS.
分析师推荐趋势
RCUS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$93M
↓ 47.8% YoY
Revenue Next Year
$95M
↑ 2.7% YoY
EPS This Year
$-3.71
EPS Next Year
$-3.44
↓ 7.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast RCUS EPS of $-3.71 for the current fiscal year, based on estimates from 7 analysts. The RCUS revenue forecast is $93M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
RCUS 股价预测由两类独立数据源支撑：来自 18 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RCUS 的共识目标价为 $31.17（+33.7% 上行空间），分析师共识为 Buy。
RCUS 的短期预测（明日）为 $23.13（-0.82%）。 RCUS 对 2027 年的股价预测均值为 $22。 RCUS 对 2030 年的预测区间为 $19–$21。
Arcus Biosciences, Inc. 在 NYSE 上市，代码 RCUS。RCUS 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
RCUS 预测 · 8 个问题根据 18 位华尔街分析师，RCUS 的 12 个月平均目标价为 $31.17，最高 $47.00、最低 $22.00。若有图表，中位目标价可在上方查看。相对当前价 $23.32，隐含约 +33.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.